ReviewBiomedicines2022
Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?
Anca Cardoneanu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it
ReviewBiomedicines2022
Anca Cardoneanu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.